COVID-19 Clinical Trials Q&A

Risk-based Monitoring - Risk-optimized approaches to clinical trials - Introduction - Part 1 of 3Подробнее

Risk-based Monitoring - Risk-optimized approaches to clinical trials - Introduction - Part 1 of 3

Impact of COVID 19 on Volunteer Interest in Clinical Trial Participation in MinnesotaПодробнее

Impact of COVID 19 on Volunteer Interest in Clinical Trial Participation in Minnesota

Quality assurance during the pandemic | Nutrastrong™ through COVID-19Подробнее

Quality assurance during the pandemic | Nutrastrong™ through COVID-19

FDA approves clinical trial application for Johnson & Johnson’s COVID-19 vaccine | ANCПодробнее

FDA approves clinical trial application for Johnson & Johnson’s COVID-19 vaccine | ANC

COVID19 QA session by Prof. V. RaviПодробнее

COVID19 QA session by Prof. V. Ravi

COVID-19 Pharmacovigilance Webinar: Adapting Hosting, Conduction of Remote Audits and InspectionsПодробнее

COVID-19 Pharmacovigilance Webinar: Adapting Hosting, Conduction of Remote Audits and Inspections

COVID and Epilepsy with QA - Prof Dr. Lim Kheng SeangПодробнее

COVID and Epilepsy with QA - Prof Dr. Lim Kheng Seang